abstract |
The present invention relates to a pharmaceutical composition, which is a tablet, having an alkalifying agent, in particular an alkali metal salt of citric acid, as the active component. By administering this pharmaceutical composition, the concentration of uremic substances in the blood is decreased and uremic substances are discharged from the body through urine. |